Ignite Creation Date:
2025-12-24 @ 3:23 PM
Ignite Modification Date:
2025-12-26 @ 1:07 AM
Study NCT ID:
NCT04738292
Status:
TERMINATED
Last Update Posted:
2024-05-03
First Post:
2021-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Sponsor:
University of Wisconsin, Madison
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-01
First Submit QC Date:
None
Study First Post Date:
2021-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-02-14
Results First Submit QC Date:
None
Results First Post Date:
2024-05-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-01
Last Update Post Date:
2024-05-03
Last Update Post Date Type:
ACTUAL